BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eltobgy M, Zani A, Kenney AD, Estfanous S, Kim E, Badr A, Carafice C, Daily K, Whitham O, Pietrzak M, Webb A, Kawahara J, Eddy AC, Denz P, Lu M, Mahesh K, Peeples ME, Li J, Zhu J, Que J, Robinson R, Mejia OR, Rayner RE, Hall-stoodley L, Seveau S, Gavrilin MA, Tedeschi A, Partida-sanchez S, Roberto F, Hemann EA, Abdelrazik E, Forero A, Nimjee SM, Boyaka P, Cormet-boyaka E, Yount JS, Amer AO. Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and thrombosis.. [DOI: 10.1101/2021.09.24.461743] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Ryan TAJ, Preston RJS, O'Neill LAJ. Immunothrombosis and the molecular control of tissue factor by pyroptosis: prospects for new anticoagulants. Biochem J 2022;479:731-50. [PMID: 35344028 DOI: 10.1042/BCJ20210522] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Premeaux TA, Yeung ST, Bukhari Z, Bowler S, Alpan O, Gupta R, Ndhlovu LC. Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies. Front Immunol 2022;13:842740. [DOI: 10.3389/fimmu.2022.842740] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]